Yoshiki Yagi

UMN Pharma, Inc. engages in the development, manufacture, and sale of biopharmaceuticals. It operates through a following business division: Next-generation biopharmaceutical in-house development business and Biopharmaceutical contract manufacturing business. The Next-generation biopharmaceutical in-house development business engages in the research and development of next-generation logical vaccine by integrating next-generation biopharmaceutical drug substance manufacturing technology, adjuvant technology and drug delivery technology. The Biopharmaceutical contract manufacturing business offers study samples, investigational drugs, products, and various evaluation test results. The company was founded by Masahiro Michishita and Shuichi Kanazashi on April 20, 2004 and is headquartered in Akita, Japan.

Sompo Japan Insurance, Inc. provides non-life insurances, including voluntary automobile, fire, marine, personal accident and compulsory automobile liability insurance. The company operates in two business segments, the non-life Insurance segment which is engaged in the non-life insurance business, as well as financial businesses and the life insurance segment which provides life insurance services. Sompo Japan was founded in 1888 and is headquartered in Tokyo, Japan.

Hitachi Capital Corp. engages in the provision of financing solutions. It operates through the following business segments: Account Solutions, Vendor Solutions, Europe, Americas, China, and ASEAN. The Account Solutions segment offers leasing, installment, insurance and trust services to its client corporations, government offices, and agricultural and medical enterprises. The Vendor Solutions segment mainly handles leasing, installment, and financing services to its partner vendors to meet their sales promotion needs. The Europe, Americas, China, and ASEAN segments provide corporate finance solutions to the wide needs of its customers and vendors in cooperation with the Hitachi group including information and medical equipment, automobiles, industrial machinery, commercial facilities, and consumer home and auto loans. The company was founded on September 10, 1957 and is headquartered in Tokyo, Japan.

Nobelpharma Co., Ltd. provides research and development of pharmaceuticals for unmet needs. Its product line encompasses orphan drugs, medicines used for additional efficacy, and pediatric medicines. The company was founded on June 6, 2003 and is headquartered in Tokyo, Japan.